Advertisement

Reactions Weekly

, Volume 1735, Issue 1, pp 21–21 | Cite as

Alectinib

Liver toxicity and drug resistance: case report
Case report
  • 14 Downloads

Reference

  1. Sehgal K, et al. Activity of Brigatinib in the Setting of Alectinib Resistance Mediated by ALK I1171S in ALK-Rearranged Lung Cancer. Journal of Thoracic Oncology 14: e1-e3, No. 1, Jan 2019 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations